@BOffersen

Professor, MD, chair of DBCG, breast cancer researcher, Aarhus University Hospital, Experimental Clinical Oncology, Danish Centre for Particle Therapy.

 Aarhus, Danmark
Joined May 2019
  • Tweets109
  • Following258
  • Followers534
8Media
Together with my colleague we have recorded a session on target volume delineation in an early breast cancer patient. It’s a one hour session with tips and tricks, link below #estro #breastcancer 🤓👇 estro.org/ESTRO/media/ESTRO/…
1
27
5
61
Excellent. High-risk pts should be offered RNI incl IMN now. The analysis also shows gain from RNI in node-negative pts and that needs to be discussed. Looking forward🧐
Matthias Guckenberger@Mat_Guc17 Dec 2023
Virtual Grand Rounds in Radiation Oncology January 10th 17:00 - 17:30 CET Prof. Carolyn Taylor: Effect of regional lymph node radiotherapy. An EBCTCG meta-analysis of 14,324 women in 16 trials Link to Zoom Meeting 👇 usz.ch/veranstaltungen/virtu…
5
26
3,160
Birgitte Offersen retweeted
Ane Appelt@cancerphysicist10 Oct 2023
I am SO excited about this!!! 🤩 We've put together a brilliant (in my humble opinion😉) line-up of speakers to discuss the challenges facing clinical re-irradiation. Please join us, it's going to be so much fun! #ReIrradiation #medphys #radonc
ESTRO@ESTRO_RT10 Oct 2023
Join the Reirradiation Webinar Series. Our experts will unravel complexities of #reirradiation throughout 8 sessions, running from Oct 2023 to May 2024. 📅 Save the Date: 1st session kicks off on 26 Oct. It's FREE! 👉 Programme and Registration: bit.ly/3RZr2ci #RadOnc
3
19
1
81
13,136
Agree. RT is postponed for those who need it following a second breast conservation. Most likely a LR in these selected pts does not lead to distant failure. We have now randomised 600 pts in the DBCG Natural trial to +- partial breast RT. Heading for 926 pts🧐
Hope Rugo@hoperugo19 Aug 2023
Really important study!! We need to avoid over treatment when it doesn't help! @OncoAlert
2
2
6
1,799
Helt enig👍. Lyder for godt til at være sandt, og jeg kan ikke finde Djævelen i detaljen…. Det ser ud til, at de mener det🤩🤓. Super måde at rekruttere, tillykke til dem, som får stillingerne🥂🧐
𝐌𝐀𝐑𝐈𝐀𝐍𝐍𝐄 𝐕𝐎𝐆𝐒𝐄𝐍@marianne_vogsen3 Jul 2023
Det her er altså en RIGTIG god ide @HerlevGentofte‼️ mindst 20% finansieret forskningstid, som led i hoveduddannelsesstilling 💪🏼en god mulighed for karriereudvikling for @YngreLaeger 👏🏼 #forskpol #uddpol #sundpol ➡️ sundhedsjobs.dk/jobopslag/45…
12
802
The figure on the cover is from the editorial—>use the ESTRO guidelines and report your results accordingly🧐. Lift the threshold for RT details when reporting RT from clinical studies: e.g. RT technique, target def., dose/fr, doses to OAR, etc
Radiotherapy & Oncology@RO_GreenJournal23 Feb 2023
Vol 179 - just published
Please visit our journal homepages for the full content: https://www.thegreenjournal.com/issue/S0167-8140(22)X0014-5 https://www.sciencedirect.com/journal/radiotherapy-and-oncology/vol/179/suppl/C

ALT Please visit our journal homepages for the full content: https://www.thegreenjournal.com/issue/S0167-8140(22)X0014-5 https://www.sciencedirect.com/journal/radiotherapy-and-oncology/vol/179/suppl/C

5
16
2,688
Radiation associated induration is closely related to irradiated breast volume in the DBCG PBI trial. Validation in the DBCG Hypo trial showed surprising and interesting findings. More info at ESTRO2023 @ESTRO_RT @RadiotherapyOn1
1
9
1
40
6,351
Link to article: pubmed.ncbi.nlm.nih.gov/3626…

Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast...

The relation between breast induration grade 2-3 at 3 years after radiation therapy and irradiated breast volume was investigated for patients in the Danish Breast Cancer Group (DBCG) Partial Breast...

pubmed.ncbi.nlm.nih.gov
3
12
443
BIGART is truly a great conference🧐. I am looking forward to the meeting⭐️
This Post is from an account that no longer exists. Learn more
1
1
6
1,195
Congratulations to Michael. What an honour to have several doctor titles 🥂🤓⭐️🇩🇰
Jens Overgaard@profOvergaard9 Sep 2022
A good day for radiation oncology and Aarhus University Professor Michael Baumann DKFZ recieve a honorary doctorate: dr.med honoris causa Congratulations
1
10
The first results from the DBCG PBI trial support standard use of external beam PBI 40Gy/15fr for selected breast cancer pts. Less morbidity and very few cancer events (not related to PBI). PBI has been DBCG standard since 2016 for low risk BC pts. Graphs & link below 👇
2
32
4
72
more replies
The pts were minimum 60 yr at randomisation (median 66 yr), and the causes of death were mostly related to non-breast disease.
2
1
9
Link to paper: ascopubs.org/doi/pdf/10.1200…
2
6
14
Birgitte Offersen retweeted
Rufus Gifford@rufusgifford22 Jul 2022
Obsessed with this – at Arlington, VA
This quoted post is unavailable.
Try viewing anyway · View on X
11
11
254
Godt gået og meget spændende. Tillykke👍
This Post is from an account that no longer exists. Learn more
1
Really interesting results. We need much more focus also on the indication for breast RT, and future trials should be developed based on hypoteses from new results on biology. @TrineTramm #radonc
MarleenKokLab@lab_kok31 Mar 2022
Out now @JCO_ASCO huge effort of our team and @TILsWorkGroup: Excellent prognosis of TNBC pts with high TILs even without chemo! Chemo de-escalation trials urgently needed! # bcsm ascopubs.org/doi/abs/10.1200…

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative...

PURPOSETriple-negative breast cancer (TNBC) is considered aggressive, and therefore, virtually all young patients with TNBC receive (neo)adjuvant chemotherapy. Increased stromal tumor-infiltrating...

ascopubs.org
8
Landsindsamling for Kræftens Bekæmpelse i Risskov i dag. Skønt vejr og mange glade givere. Mere end 60% af beløbet går til forskning. Forhåbentlig flere kliniske studier til gavn for patienterne @cancer_dk
23
Excellent and well done #AUH #oncology
Frede Donskov@FDonskov29 Mar 2022
Dr @AskaDrljevic presenting and being awarded her brilliant PhD. Advanced CT-derived biomarkers in #metastatic #kidney #cancer showing prognostic ability - and #functional #imaging outperforms tumor biopsies in assessing microvessels due to tumor heterogeneity.
1
3
Load more